臨床検査サービスの世界市場予測(~2022年)

◆英語タイトル:Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) - Global Forecasts to 2022
◆商品コード:MAM-MD-5847
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2017年12月21日
◆ページ数:169
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
MarketsandMarketsが発行した当調査レポートでは、臨床検査サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、専門別分析、プロバイダー別分析、地域別分析、臨床検査サービスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

Clinical laboratory services market projected to grow at a CAGR of 5.2%
The clinical laboratory services market is projected to reach USD 146.14 billion by 2022 from USD 113.44 billion in 2017, at a CAGR of 5.2%. The increasing global burden of target diseases, advancements in clinical diagnostic techniques, and rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures are the major factors driving the demand for clinical laboratory services market. Factors such as the pricing pressure faced by healthcare payers and providers and the procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures are limiting the growth of the market to a certain extent.

The genetic testing segment is expected to witness the highest growth during the forecast period
In 2017, on the basis of specialty, the genetic testing segment is expected to register the highest growth rate during the forecast period, due to growing adoption of precision medicine and increasing awareness among people about preventive care.
The independent & reference laboratories segment is poised to be the fastest growing during the forecast period
In 2017, on the basis of provider, the independent & reference laboratories segment is expected to register the highest growth rate during the forecast period, owing to a global focus on patient diagnosis for target diseases worldwide and the competitive benefits offered by providers over hospital-based laboratories.

Asia Pacific is expected to register the highest growth rate during the forecast period
Geographically, the clinical laboratory services market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest growth rate during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, and a significant rise in the disposable income among their middle-class population.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type – Tier 1 – 48%, Tier 2 – 40% and Tier 3 – 12%
• By Designation – C-level – 26%, Director-level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, South America – 9% and Middle East – 8%

The global clinical laboratory services market is competitive, with a large number of global and local players. In 2016, the market was dominated by Mayo Medical Laboratories (US), LabCorp (US), and Quest Diagnostics (US). Service launches, upgrades, and approvals; agreements, partnerships, and collaborations were the major strategies adopted by market players to achieve growth in the market.

Research Coverage
This report studies the clinical laboratory services market based on specialty, provider, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:
This research report focuses on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the clinical laboratory services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn can help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on service portfolios offered by the major players in the clinical laboratory services market. The report analyzes the clinical laboratory services market based on specialty, provider, and region
• New Service Development: Detailed insights on the research and development activities and service launches in the clinical laboratory services market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various clinical laboratory services across geographies
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the clinical laboratory services market
• Competitive Assessment: In-depth assessment of market ranking, strategies, service portfolios, distribution networks, and providers capabilities of leading players in the clinical laboratory services market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKETS COVERED 15
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 20
2.1.1.1 Secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 22
2.1.2.2 Key data from primary sources 22
2.2 MARKET SIZE ESTIMATION 23
2.2.1 BOTTOM-UP APPROACH 23
2.2.2 TOP-DOWN APPROACH 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 CLINICAL LABORATORY SERVICES MARKET OVERVIEW 31
4.2 CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 32
4.3 CLINICAL LABORATORY SERVICES PROVIDER MARKET, BY REGION 33
4.4 GEOGRAPHIC SNAPSHOT: CLINICAL LABORATORY SERVICES MARKET 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Increasing global burden of target diseases 36
5.2.1.2 Rising demand for early and accurate disease diagnosis 37
5.2.1.3 Advancements in clinical diagnostic techniques 37
5.2.1.4 Growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures 38
5.2.1.5 Rising government initiatives to improve the quality and affordability of clinical diagnostic testing procedures 39
5.2.2 RESTRAINTS 40
5.2.2.1 Pricing pressure faced by healthcare payers and providers 40
5.2.2.2 Procedural shift from lab-based diagnosis to home-based/point-of-care testing procedures 40
5.2.3 OPPORTUNITIES 41
5.2.3.1 Emerging countries 41
5.2.3.2 Patient-initiated diagnostic testing to foster market growth in developed countries 42
5.2.3.3 Growing adoption of digital pathology platforms 42
5.2.3.4 Rising preference for comprehensive health checkups offered by clinical laboratories 42
5.2.4 CHALLENGE 43
5.2.4.1 Public concerns related to data security and privacy 43
6 CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 44
6.1 INTRODUCTION 45
6.2 CLINICAL CHEMISTRY TESTING 46
6.2.1 ROUTINE CHEMISTRY TESTING 48
6.2.2 ENDOCRINOLOGY CHEMISTRY TESTING 49
6.2.3 THERAPEUTIC DRUG MONITORING (TDM) TESTING 50
6.2.4 SPECIALIZED CHEMISTRY TESTING 51
6.2.5 OTHER CLINICAL CHEMISTRY TESTING 51
6.3 MICROBIOLOGY TESTING 52
6.3.1 INFECTIOUS DISEASE TESTING 55
6.3.2 TRANSPLANT DIAGNOSTIC TESTING 56
6.3.3 OTHER MICROBIOLOGY TESTING 57
6.4 HEMATOLOGY TESTING 58
6.4.1 ROUTINE HEMATOLOGY TESTING 60
6.4.2 COAGULATION TESTING 60
6.4.3 SPECIALIZED HEMATOLOGY TESTING 61
6.5 IMMUNOLOGY TESTING 62
6.6 CYTOLOGY TESTING 64
6.7 GENETIC TESTING 66
6.8 DRUGS OF ABUSE TESTING 68

7 CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER 70
7.1 INTRODUCTION 71
7.2 INDEPENDENT & REFERENCE LABORATORIES 72
7.3 HOSPITAL-BASED LABORATORIES 73
7.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES 74
8 CLINICAL LABORATORY SERVICES MARKET, BY REGION 75
8.1 INTRODUCTION 76
8.2 NORTH AMERICA 77
8.2.1 US 80
8.2.2 CANADA 82
8.3 EUROPE 83
8.3.1 GERMANY 85
8.3.2 UK 86
8.3.3 FRANCE 87
8.3.4 REST OF EUROPE (ROE) 88
8.4 ASIA PACIFIC 90
8.4.1 JAPAN 92
8.4.2 CHINA 93
8.4.3 INDIA 94
8.4.4 REST OF ASIA PACIFIC (ROAPAC) 95
8.5 REST OF THE WORLD (ROW) 97
9 COMPETITIVE LANDSCAPE 100
9.1 OVERVIEW 100
9.2 MARKET RANKING ANALYSIS 101
9.3 COMPETITIVE SCENARIO 102
9.3.1 SERVICE LAUNCHES, UPGRADES, AND APPROVALS 103
9.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 104
9.3.3 ACQUISITIONS 104
9.3.4 EXPANSIONS 105
10 COMPANY PROFILES 106
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
10.1 MAYO MEDICAL LABORATORIES 106
10.2 LABCORP 112
10.3 QUEST DIAGNOSTICS 118
10.4 SPECTRA LABORATORIES 125
10.5 DAVITA HEALTHCARE PARTNERS 128
10.6 EUROFINS SCIENTIFIC 130
10.7 UNILABS 135
10.8 SYNLAB INTERNATIONAL 137
10.9 BIO-REFERENCE LABORATORIES 138
10.10 SONIC HEALTHCARE 140
10.11 CLINICAL REFERENCE LABORATORY 144
10.12 ACM MEDICAL LABORATORY 146
10.13 ADICON CLINICAL LABORATORY 148
10.14 CERBA HEALTHCARE 150
10.15 AMEDES HOLDING 153
10.16 LIFELABS MEDICAL LABORATORIES 155

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.
11 APPENDIX 158
11.1 DISCUSSION GUIDE 158
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 162
11.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 164
11.4 AVAILABLE CUSTOMIZATIONS 165
11.5 RELATED REPORTS 166
11.6 AUTHOR DETAILS 167

LIST OF TABLES

TABLE 1 GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 45
TABLE 2 GLOBAL CLINICAL CHEMISTRY TESTING MARKET, BY TYPE,
2015–2022 (USD BILLION) 46
TABLE 3 CLINICAL CHEMISTRY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 47
TABLE 4 EUROPE: CLINICAL CHEMISTRY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 47
TABLE 5 NORTH AMERICA: CLINICAL CHEMISTRY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 47
TABLE 6 ASIA PACIFIC: CLINICAL CHEMISTRY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 48
TABLE 7 ROUTINE CHEMISTRY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 49
TABLE 8 ENDOCRINOLOGY CHEMISTRY TESTING MARKET, BY REGION,
2015–2022 (USD BILLION) 49
TABLE 9 THERAPEUTIC DRUG MONITORING (TDM) TESTING MARKET,
BY REGION, 2015–2022 (USD MILLION) 50
TABLE 10 SPECIALIZED CHEMISTRY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 51
TABLE 11 OTHER CLINICAL CHEMISTRY TESTING MARKET, BY REGION,
2015–2022 (USD BILLION) 52
TABLE 12 GLOBAL MICROBIOLOGY TESTING MARKET, BY TYPE, 2015–2022 (USD BILLION) 53
TABLE 13 MICROBIOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 53
TABLE 14 EUROPE: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 53
TABLE 15 NORTH AMERICA: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 54
TABLE 16 ASIA PACIFIC: MICROBIOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 54
TABLE 17 INFECTIOUS DISEASE TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 55
TABLE 18 TRANSPLANT DIAGNOSTIC TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 56
TABLE 19 OTHER MICROBIOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 20 GLOBAL HEMATOLOGY TESTING MARKET, BY TYPE, 2015-2022 (USD BILLION) 58
TABLE 21 HEMATOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 58
TABLE 22 EUROPE: HEMATOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 59
TABLE 23 NORTH AMERICA: HEMATOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 59
TABLE 24 ASIA PACIFIC: HEMATOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 59
TABLE 25 ROUTINE HEMATOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 60
TABLE 26 COAGULATION TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 61
TABLE 27 SPECIALIZED HEMATOLOGY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 61
TABLE 28 IMMUNOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 62
TABLE 29 EUROPE: IMMUNOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 62
TABLE 30 NORTH AMERICA: IMMUNOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 63
TABLE 31 ASIA PACIFIC: IMMUNOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 63
TABLE 32 CYTOLOGY TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 64
TABLE 33 EUROPE: CYTOLOGY TESTING MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 34 NORTH AMERICA: CYTOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 65
TABLE 35 ASIA PACIFIC: CYTOLOGY TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 65
TABLE 36 GENETIC TESTING MARKET, BY REGION, 2015–2022 (USD BILLION) 66
TABLE 37 EUROPE: GENETIC TESTING MARKET, BY COUNTRY, 2015–2022 (USD BILLION) 66
TABLE 38 NORTH AMERICA: GENETIC TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 67
TABLE 39 ASIA PACIFIC: GENETIC TESTING MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 67
TABLE 40 DRUGS OF ABUSE TESTING MARKET, BY REGION, 2015–2022 (USD MILLION) 68
TABLE 41 EUROPE: DRUGS OF ABUSE TESTING MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 69
TABLE 42 NORTH AMERICA: DRUGS OF ABUSE TESTING MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 69
TABLE 43 ASIA PACIFIC: DRUGS OF ABUSE TESTING MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 69
TABLE 44 GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER,
2015-2022 (USD BILLION) 71
TABLE 45 CLINICAL LABORATORY SERVICES MARKET FOR INDEPENDENT & REFERENCE LABORATORIES, BY REGION, 2015-2022 (USD BILLION) 72
TABLE 46 CLINICAL LABORATORY SERVICES MARKET FOR HOSPITAL-BASED LABORATORIES, BY REGION, 2015-2022 (USD BILLION) 73
TABLE 47 CLINICAL LABORATORY SERVICES MARKET FOR NURSING & PHYSICIAN OFFICE-BASED LABORATORIES, BY REGION, 2015-2022 (USD BILLION) 74
TABLE 48 CLINICAL LABORATORY SERVICES MARKET, BY REGION,
2015–2022 (USD BILLION) 77
TABLE 49 NORTH AMERICA: CLINICAL LABORATORY SERVICES MARKET,
BY COUNTRY, 2015–2022 (USD BILLION) 79
TABLE 50 NORTH AMERICA: CLINICAL LABORATORY SERVICES MARKET,
BY SPECIALTY, 2015–2022 (USD BILLION) 79
TABLE 51 NORTH AMERICA: CLINICAL LABORATORY SERVICES MARKET,
BY PROVIDER, 2015–2022 (USD BILLION) 80
TABLE 52 US: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 81
TABLE 53 CANADA: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 82
TABLE 54 EUROPE: CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 84
TABLE 55 EUROPE: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 84
TABLE 56 EUROPE: CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER,
2015–2022 (USD BILLION) 85
TABLE 57 GERMANY: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 86
TABLE 58 UK: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 87
TABLE 59 FRANCE: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 88
TABLE 60 ROE: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 89
TABLE 61 ASIA PACIFIC: CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY,
2015–2022 (USD BILLION) 91
TABLE 62 ASIA PACIFIC: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 91
TABLE 63 ASIA PACIFIC: CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER,
2015–2022 (USD BILLION) 92
TABLE 64 JAPAN: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 93
TABLE 65 CHINA: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 94
TABLE 66 INDIA: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 95
TABLE 67 ROAPAC: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 96
TABLE 68 ROW: CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY,
2015–2022 (USD BILLION) 98
TABLE 69 ROW: CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER,
2015–2022 (USD BILLION) 99
TABLE 70 TOP 5 SERVICE LAUNCHES, UPGRADES, AND APPROVALS, 2014–2017 103
TABLE 71 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014–2017 104
TABLE 72 TOP 5 ACQUISITIONS, 2014–2017 104
TABLE 73 EXPANSIONS, 2014–2017 105


LIST OF FIGURES

FIGURE 1 GLOBAL CLINICAL LABORATORY SERVICES MARKET: RESEARCH METHODOLOGY STEPS 18
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 CLINICAL LABORATORY SERVICES MARKET: BOTTOM-UP APPROACH 23
FIGURE 4 CLINICAL LABORATORY SERVICES MARKET: TOP-DOWN APPROACH 24
FIGURE 5 DATA TRIANGULATION METHODOLOGY 25
FIGURE 6 CLINICAL CHEMISTRY TESTING SEGMENT IS EXPECTED TO DOMINATE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET DURING FORECAST PERIOD 27
FIGURE 7 ROUTINE CHEMISTRY TESTING SEGMENT TO DOMINATE THE CLINICAL CHEMISTRY MARKET DURING FORCAST PERIOD 28
FIGURE 8 INDEPENDENT AND REFERENCE LABORATORIES EXPECTED TO BE THE FASTEST-GROWING SEGMENT DURING 2017-2022 28
FIGURE 9 ASIA PACIFIC TO GROW AT THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 29
FIGURE 10 RISING GLOBAL BURDEN OF TARGET DISEASES TO DRIVE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET DURING THE FORECAST PERIOD 31
FIGURE 11 CLINICAL CHEMISTRY TESTING TO DOMINATE THE GLOBAL CLINICAL LABORATORY SERVICES MARKET DURING THE FORECAST PERIOD 32
FIGURE 12 EUROPE TO DOMINATE CLINICAL LABORATORY SERVICES PROVIDER MARKET
IN 2017 33
FIGURE 13 INDIA AND CHINA ARE THE FASTEST GROWING COUNTRIES IN GLOBAL CLINICAL LABORATORY SERVICES MARKET 34
FIGURE 14 CLINICAL LABORATORY SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 35
FIGURE 15 GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
(2017 VS. 2022) 45
FIGURE 16 GLOBAL CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
(2017 VS. 2022) 71
FIGURE 17 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS THE HIGHEST DEMAND GROWTH FOR CLINICAL LABORATORY SERVICES DURING THE FORECAST PERIOD 76
FIGURE 18 NORTH AMERICA: CLINICAL LABORATORY SERVICES MARKET SNAPSHOT 78
FIGURE 19 EUROPE: CLINICAL LABORATORY SERVICES MARKET SNAPSHOT 83
FIGURE 20 ASIA PACIFIC: CLINICAL LABORATORY SERVICES MARKET SNAPSHOT 90
FIGURE 21 ROW: CLINICAL LABORATORY SERVICES MARKET SNAPSHOT 97
FIGURE 22 KEY DEVELOPMENTS ADOPTED BY LEADING PLAYERS IN CLINICAL LABORATORY MARKET BETWEEN 2014 AND 2017 100
FIGURE 23 GLOBAL CLINICAL LABORATORY SERVICES MARKET RANKING, BY KEY SERVICE PROVIDERS, 2016 101
FIGURE 24 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH: COMPANY SNAPSHOT 106
FIGURE 25 LABCORP: COMPANY SNAPSHOT 112
FIGURE 26 QUEST DIAGNOSTICS: COMPANY SNAPSHOT 118
FIGURE 27 FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT 125
FIGURE 28 DAVITA HEALTHCARE PARTNERS: COMPANY SNAPSHOT 128

FIGURE 29 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 130
FIGURE 30 OPKO HEALTH .: COMPANY SNAPSHOT 138
FIGURE 31 SONIC HEALTHCARE: COMPANY SNAPSHOT 140


【レポートのキーワード】

臨床検査サービス、臨床検査室

★調査レポート[臨床検査サービスの世界市場予測(~2022年)] (コード:MAM-MD-5847)販売に関する免責事項を必ずご確認ください。
★調査レポート[臨床検査サービスの世界市場予測(~2022年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆